FDA aims to expand disclosure of advisers' ties to companies

04/21/2010 | Star Tribune (Minneapolis-St. Paul, Minn.)

The FDA proposed that detailed information be disclosed about financial ties between advisory panel members and companies with medical products under evaluation whenever the agency grants a conflict-of-interest waiver. FDA Commissioner Margaret Hamburg said the move would allow the agency to "obtain needed input and maintain external credibility." The agency said it would gather feedback on the proposal for two months.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC